SYNERGISTIC PHARMACEUTICAL COMBINATION COMPRISING AN ESTROGEN RECEPTOR ANTAGONIST AND A PROGESTIN

2010
Other OA: closed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-10 ⓘ

This invention discloses a pharmaceutical combination of an estrogen receptor antagonist and a progestin for the treatment of gynecological diseases caused by abnormal uterine tissue growth, including endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The present invention relates to the coadministration of an estrogen receptor antagonist and a progestin to treat gynecological diseases resulting from abnormal growth of uterine tissue, such as endometriosis or uterine fibroids.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-22T06:15:05.045840+00:00